Summary
Chipotle Mexican Grill Inc. (CMG) filed an 8-K on January 6, 2016, providing a critical update on its financial and operating performance for the fourth quarter and December 2015. The company anticipates a significant decline in comparable restaurant sales for Q4 2015 at -14.6%, exacerbated by the E. coli incidents in October/November and a subsequent norovirus outbreak in Brighton, Massachusetts, in December. This negative trend continued through December, with comparable sales dropping to an average of -34% following the norovirus incident and further declining to -37% after new E. coli cases were reported by the CDC. The company also disclosed an estimate of $14.0 to $16.0 million in non-recurring expenses for Q4 2015, covering costs associated with food replacement, lab analysis, increased marketing, expert advisory services, and preliminary legal expenses. Restaurant-level operating margins are projected to be around 20%-21%, and diluted EPS is expected to be between $1.70 and $1.90, subject to year-end adjustments. Furthermore, Chipotle announced it has received a Federal Grand Jury Subpoena related to an August 2015 norovirus incident, indicating an ongoing criminal investigation. Despite these challenges, the Board authorized an additional $300 million in share repurchases, adding to a previous authorization.
Key Highlights
- 1Comparable restaurant sales for Q4 2015 are projected to be negative at -14.6%.
- 2December 2015 comparable restaurant sales were severely impacted, averaging -30% for the full month, with a low of -37% following new E. coli case reports.
- 3Non-recurring expenses for Q4 2015 are estimated between $14.0 million and $16.0 million, covering costs related to food safety incidents and increased marketing.
- 4Restaurant-level operating margins are expected to be in the range of 20% to 21% for Q4 2015.
- 5Diluted earnings per share (EPS) for Q4 2015 are forecast to be between $1.70 and $1.90.
- 6Chipotle has received a Federal Grand Jury Subpoena related to a prior norovirus incident, indicating an ongoing criminal investigation.
- 7An additional $300 million share repurchase program has been authorized by the Board of Directors.